Assay Detail
Functional
CHEMBL5609747
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiplasmodial activity against Plasmodium falciparum Dd2 infected in erythrocytes assessed as inhibition of parasite growth incubated for 72 hrs by [3H]hypoxanthine incorporation based microbeta counting analysis
7
Total Activities
7
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Plasmodium falciparum |
| Cell Type | Erythrocyte |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 7 | 8.03 | 9.00 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL4091762 | CABAMIQUINE | 2.0 | 1 | 9.00 |
| CHEMBL5613620 | — | — | 1 | 8.40 |
| CHEMBL1956285 | DSM-265 | 2.0 | 1 | 8.22 |
| CHEMBL2041980 | MMV-048 | 2.0 | 1 | 7.92 |
| CHEMBL2431810 | — | — | 1 | 7.85 |
| CHEMBL2058833 | GANAPLACIDE | 2.0 | 1 | 7.77 |
| CHEMBL5612025 | — | — | 1 | 7.06 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL4091762 | CABAMIQUINE | EC50 | = | 1.0 | nM | 9.00 |
| CHEMBL5613620 | — | EC50 | = | 4.0 | nM | 8.40 |
| CHEMBL1956285 | DSM-265 | EC50 | = | 6.0 | nM | 8.22 |
| CHEMBL2041980 | MMV-048 | EC50 | = | 12.0 | nM | 7.92 |
| CHEMBL2431810 | — | EC50 | = | 14.0 | nM | 7.85 |
| CHEMBL2058833 | GANAPLACIDE | EC50 | = | 17.0 | nM | 7.77 |
| CHEMBL5612025 | — | EC50 | = | 88.0 | nM | 7.06 |